Research Paper Volume 14, Issue 5 pp 2383—2399
Establishing a cancer driver gene signature-based risk model for predicting the prognoses of gastric cancer patients
Figure 1. Expression levels of cancer driver genes (CDGs) and their alterations in gastric cancer (GC). (A) CDG mRNA expression levels in GC obtained from The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD). (B) Expression levels of proteins encoded by CDGs in normal tissues as obtained from the Human Protein Atlas (HPA) database (Data for GLAP1 was not available at HPA database).